Renal, vesical and cutaneous disorders / American Apothecaries Company.

  • American Apothecaries Company
Date:
[between 1920 and 1929?]
Catalogue details

Licence: Public Domain Mark

Credit: Renal, vesical and cutaneous disorders / American Apothecaries Company. Source: Wellcome Collection.

    9/16 page 7
    and a genuine kidney inflammation or Nephritis supervenes. Earzy Bricut’s Disease: Thus, we have the early beginning of Bright’s Disease. It is quite | evident that prompt elimination of the retained excretory products is the predominant thera- peutic indication, and a real life-conserving measure. _ How is this purpose best and most conven- iently accomplished? Manifestly, by encouraging the “opening up” of every avenue of excretion, i.e., the en- ‘couragement, enhancement, acceleration and increase of the functions of skin, lungs, intestine and urinary tract. It is right here that Salvitae takes its place as the agent “ par excellence’. A careful consideration of its formula will serve to demonstrate its rational and compre- hensive utility in accordance with the following - definite principles: _ Firstasan Alkalinizing Agent, each and every ingredient contributing its share of thera- peutic activity as a de-acidifier. med J e ° es ° . Second as a Diuretic, the strontium, lithium, f sodium, magnesium and potassium salts being reinforced by the more actively diu-
    digitised image 1
    digitised image 2
    digitised image 3